Search
for
Sort by
Research 451–480 of 1000+
- Anabolic-androgenic steroids and cardiovascular risk
- Respiratory, Dermal, and Eye Irritation Symptoms Associated with Corexit™ EC9527A/EC9500A following the <i>Deepwater Horizon</i> Oil Spill: Findings from the GuLF STUDY
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- Joint study of the associations of HLA‐B and the transmembrane short tandem repeat polymorphism of MICA protein with alopecia areata shows independent associations of both with the disease
- Transitory hair growth using platelet‐rich plasma therapy in stabilized central centrifugal cicatricial alopecia
- Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-analysis
- Spironolactone May Reduce the Risk of Incident Rosacea
- How to Read a Research Paper
- Association Between Premature Hair Greying and Metabolic Risk Factors: A Cross-sectional Study
- Familial hypertriglyceridemia in pregnancy
- Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase
- Bidirectional association between alopecia areata and migraine: A nationwide population-based cohort study
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Glycol Ethers and Neurodevelopment: Investigating the Impact of Prenatal Exposures
- 0914 Association Between Obstructive Sleep Apnea, Nightmare Disorder and Incident Herpes Zoster
- Response to: “finasteride prescribed for hair loss consistently leads to depression”
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Association between hair loss and cardiometabolic diseases in Chinese adults: a cross-sectional analysis in Tianning Cohort
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Serum Paroxonase 1 Level and Androgenetic Alopecia: Correspondence
- The Incidence of Alopecia Areata in a COVID-19-Vaccinated Population: A Single-Center Review
- Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis
- Acute and Chronic Telogen Effluvium
- The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH.
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- 5-Alpha-Reductase Inhibitor Treatment for Frontal Fibrosing Alopecia:A Myth or Truth?
- Chemically Induced Hair Loss/Alopecia
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Follicle trauma and the role of the dissecting microscope in hair transplantation